LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2015 to Q4 2021

Type / Class
Debt / NOTE 5.250%12/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2021 Q4 $0 $0 -$11,722,020 0
2021 Q3 $11,630,000 $11,722,020 101.32% 5
2021 Q2 $11,630,000 $11,690,752 100.0% 5
2021 Q1 $11,630,000 $12,572,059 110.0% 5
2020 Q4 $11,630,000 $10,188,999 86.66% 5
2020 Q3 $11,630,000 $9,290,664 -$12,189,375 78.88% 5
2020 Q2 $32,839,000 $14,774,121 40.75% 8
2020 Q1 $90,639,000 $47,089,416 48.0% 12
2019 Q4 $88,139,000 $66,588,984 -$77,014 74.17% 11
2019 Q3 $88,239,000 $58,179,340 65.78% 11
2019 Q2 $88,239,000 $95,335,801 +$253,292 107.49% 11
2019 Q1 $88,209,000 $89,933,200 -$93,250 101.27% 11
2018 Q4 $88,209,000 $98,475,785 111.95% 10
2018 Q3 $87,209,000 $129,842,575 149.36% 9
2018 Q2 $87,209,000 $140,276,471 +$9,641 161.15% 9
2018 Q1 $87,209,000 $113,493,235 -$386,757 129.91% 9
2017 Q4 $87,500,000 $124,162,001 141.73% 7
2017 Q3 $87,500,000 $144,625,500 -$14,131 162.97% 7
2017 Q2 $87,500,000 $182,446,200 +$658,919 207.92% 8
2017 Q1 $87,500,000 $163,115,080 +$1,533,106 186.11% 7
2016 Q4 $87,500,000 $157,420,000 -$46,449 179.88% 9
2016 Q3 $87,500,000 $198,101,000 +$5,099,540 226.0% 9
2016 Q2 $87,625,000 $164,382,000 +$3,194,558 187.52% 12
2016 Q1 $87,500,000 $141,157,000 +$3,228,692 161.46% 12
2015 Q4 $85,350,000 $149,424,000 +$135,370,000 174.87% 12